# Study to Evaluate SC Route of Administration of Ofatumumab in RA Patients

> **NCT00686868** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 35 (actual)

## Conditions studied

- Arthritis, Rheumatoid

## Interventions

- **OTHER:** placebo
- **DRUG:** ofatumumab

## Key facts

- **NCT ID:** NCT00686868
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06-13
- **Primary completion:** 2011-03-11
- **Final completion:** 2011-05-02
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2017-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00686868

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00686868, "Study to Evaluate SC Route of Administration of Ofatumumab in RA Patients". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00686868. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*